RU2184544C1
|
|
Antiallergic preparation
|
RU2021816C1
|
|
Method of preparing of vaccine against cholera
|
RU2021817C1
|
|
Method of preparing of vaccine against cholera
|
SU1824738A1
|
|
Method of preparing of modified allergens
|
RU1803928C
|
|
Method of modelling of allergic states in experimental animals
|
RU2003350C1
|
|
Method of treatment for glucocorticosteroid dependent atopic diseases
|
RU1777085C
|
|
Method for identifying regional transformation of lymphocytes
|
SU1761808A1
|
|
Dna fragment encoding surface protein part of sd4t of human lymphocytes responsible for binding with protein dp120 of human immunodeficiency virus
|
SU1767517A1
|
|
Peritoneal microphag induction stimulator for tested animal
|
SU1727078A1
|
|
Method of killer activity determination
|
SU1719432A1
|
|
Method of virus antigen isolation
|
SU1696433A1
|
|
Method of n-isobutyryl-6-0-[2-(4-nitrophenyl)ethyl]-5'-0-dimethoxytrityl-2'- deoxyguanosine preparation
|
SU1712880A1
|
|
Method for determining the leukocyte chemotaxis
|
SU1697008A1
|
|
Method of leukocyte adhesion estimation
|
SU1655983A1
|
|
Method for culture of respiratory-syncytial virus
|
EP0382848A1
|
|
STRAIN OF HYBRIDOME C10G7-PRODUCER OF MONOCLONE ANTIBODIES TO THE FAMILY OF BETA-CELL ANTIGENS OF THE PANCREAS HAVING A MOLECULAR MASS OF 64-69kD
|
SU1578658A1
|
|
Method of induction of suppression cells in peripheral blood of people
|
SU1596252A1
|
|
Method of determining migration ability of macrophagocytes and leukocytes
|
SU1580617A1
|
|
Method of preparing vaccine against influenza virus
|
SU1527594A1
|
|
Method of diagnosis of insulin-dependent diabetes mellitus
|